Form 4 for SRPT Sarepta Therapeutics, Inc.
Accepted 2024-11-29 00:00:00 ET · period of report 2024-11-26 · accession 0000950170-24-131938 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-29 | 2024-11-26 | SRPT | Rothfuss Cristin | EVP, GC | A - Grant | $0.00 | +2,000 | 13.8K | +17% | $0 |
| D | 2024-11-29 | 2024-11-26 | SRPT | Rothfuss Cristin | EVP, GC | A - Grant | $0.00 | +4,000 | 4,000 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-26 | A | A | 2,000 | $0.00 | 13,817 | D | — | — | (F1) The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date. |
| 2 | Derivative | Stock Option (right to buy) | 2024-11-26 | A | A | 4,000 | $0.00 | 4,000 | D | $130.50 · 2025-11-26 to 2034-11-26 | 4,000 Common Stock | (F2) Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter. |